BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11411809)

  • 1. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
    Lu L; Su WJ; Yue W; Ge X; Su F; Pei G; Ma L
    Life Sci; 2001 May; 69(1):37-46. PubMed ID: 11411809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do antidepressants affect motivation in conditioned place preference?
    Subhan F; Deslandes PN; Pache DM; Sewell RD
    Eur J Pharmacol; 2000 Nov; 408(3):257-63. PubMed ID: 11090642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: Role of inflammatory cytokines and nitric oxide.
    Mansouri MT; Naghizadeh B; Ghorbanzadeh B; Amirgholami N; Houshmand G; Alboghobeish S
    Metab Brain Dis; 2020 Feb; 35(2):305-313. PubMed ID: 31630319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of venlafaxine on ethanol withdrawal syndrome in rats.
    Sağlam E; Uzbay IT; Kayir H; Celik T; Beyazyürek M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):693-8. PubMed ID: 15548241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model.
    Cegielska-Perun K; Bujalska-Zadrożny M; Makulska-Nowak HE
    Pharmacol Rep; 2012; 64(5):1267-75. PubMed ID: 23238483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.
    Ozdemir E; Gursoy S; Bagcivan I
    J Physiol Sci; 2012 Jul; 62(4):317-23. PubMed ID: 22544464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Wu CC; Chen JY; Tao PL; Chen YA; Yeh GC
    Eur J Pharmacol; 2005 Apr; 512(1):37-42. PubMed ID: 15814088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food deprivation facilitates reinstatement of morphine-induced conditioned place preference: Role of intra-accumbal dopamine D2-like receptors in associating reinstatement of morphine CPP with stress.
    Sadeghzadeh F; Babapour V; Haghparast A
    Synapse; 2017 Apr; 71(4):. PubMed ID: 27902847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
    Rezayat M; Azizi N; Zarrindast MR
    Pharmacol Toxicol; 1997 Sep; 81(3):124-9. PubMed ID: 9335069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride injections into the medial septum reverse the influence of intra-medial septum injection of L-arginine on expression of place conditioning-induced by morphine in rats.
    Karami M; Zarrindast MR; Sepehri H; Sahraei H
    Brain Res; 2003 Jun; 976(1):30-40. PubMed ID: 12763619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.